Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgical Flaps | 41 | 2024 | 250 | 7.080 |
Why?
|
Burns | 34 | 2024 | 141 | 6.220 |
Why?
|
Free Tissue Flaps | 11 | 2022 | 49 | 4.540 |
Why?
|
Microsurgery | 11 | 2022 | 91 | 1.920 |
Why?
|
Sex Reassignment Surgery | 5 | 2022 | 42 | 1.740 |
Why?
|
Penis | 8 | 2022 | 61 | 1.600 |
Why?
|
Frostbite | 4 | 2019 | 8 | 1.580 |
Why?
|
Skin Transplantation | 10 | 2019 | 184 | 1.520 |
Why?
|
Anastomosis, Surgical | 10 | 2019 | 277 | 1.460 |
Why?
|
Rectus Abdominis | 5 | 2024 | 40 | 1.350 |
Why?
|
Perforator Flap | 3 | 2017 | 12 | 1.170 |
Why?
|
Hand Injuries | 5 | 2017 | 16 | 1.160 |
Why?
|
Household Articles | 2 | 2021 | 15 | 1.130 |
Why?
|
Microwaves | 2 | 2021 | 36 | 1.120 |
Why?
|
Debridement | 9 | 2019 | 59 | 1.110 |
Why?
|
Tissue and Organ Harvesting | 4 | 2013 | 79 | 1.100 |
Why?
|
Urethra | 5 | 2022 | 116 | 1.090 |
Why?
|
Scalp | 4 | 2010 | 72 | 1.060 |
Why?
|
Hernia, Hiatal | 2 | 2024 | 38 | 1.060 |
Why?
|
Accidents, Home | 2 | 2021 | 16 | 1.050 |
Why?
|
Male | 79 | 2024 | 42658 | 1.030 |
Why?
|
Humans | 127 | 2024 | 89925 | 1.010 |
Why?
|
Wounds and Injuries | 5 | 2012 | 264 | 0.950 |
Why?
|
Bone Transplantation | 2 | 2015 | 67 | 0.920 |
Why?
|
Head and Neck Neoplasms | 5 | 2017 | 1061 | 0.920 |
Why?
|
Negative-Pressure Wound Therapy | 4 | 2015 | 10 | 0.920 |
Why?
|
Retrospective Studies | 32 | 2023 | 9203 | 0.920 |
Why?
|
Child, Preschool | 22 | 2023 | 3769 | 0.910 |
Why?
|
Veins | 5 | 2018 | 95 | 0.900 |
Why?
|
Thigh | 4 | 2013 | 39 | 0.900 |
Why?
|
Female | 71 | 2024 | 46572 | 0.890 |
Why?
|
Herniorrhaphy | 2 | 2024 | 91 | 0.880 |
Why?
|
Foot Injuries | 3 | 2017 | 10 | 0.870 |
Why?
|
Transgender Persons | 3 | 2022 | 109 | 0.860 |
Why?
|
Recurrence | 4 | 2024 | 1145 | 0.860 |
Why?
|
Forearm | 5 | 2018 | 31 | 0.840 |
Why?
|
Mediastinitis | 5 | 2015 | 14 | 0.840 |
Why?
|
Skull | 2 | 2015 | 255 | 0.820 |
Why?
|
Ethical Analysis | 2 | 2022 | 23 | 0.810 |
Why?
|
Limb Salvage | 2 | 2019 | 35 | 0.800 |
Why?
|
Adult | 53 | 2024 | 26811 | 0.800 |
Why?
|
Vascularized Composite Allotransplantation | 1 | 2022 | 14 | 0.790 |
Why?
|
Abdominal Wall | 2 | 2013 | 30 | 0.770 |
Why?
|
Middle Aged | 50 | 2024 | 26133 | 0.770 |
Why?
|
Transsexualism | 3 | 2018 | 34 | 0.760 |
Why?
|
Aged, 80 and over | 22 | 2024 | 6780 | 0.750 |
Why?
|
Patient Satisfaction | 4 | 2018 | 460 | 0.740 |
Why?
|
Thrombosis | 2 | 2021 | 302 | 0.720 |
Why?
|
Child | 25 | 2023 | 7242 | 0.710 |
Why?
|
Adolescent | 24 | 2022 | 9339 | 0.700 |
Why?
|
Postoperative Complications | 13 | 2019 | 2314 | 0.700 |
Why?
|
Surgical Tape | 2 | 2010 | 4 | 0.680 |
Why?
|
Fascia | 5 | 2021 | 31 | 0.670 |
Why?
|
Child Abuse | 2 | 2017 | 85 | 0.670 |
Why?
|
Stevens-Johnson Syndrome | 4 | 2021 | 22 | 0.660 |
Why?
|
Aged | 37 | 2024 | 19241 | 0.660 |
Why?
|
Dermatologic Surgical Procedures | 2 | 2017 | 16 | 0.630 |
Why?
|
Vascular Grafting | 1 | 2018 | 16 | 0.620 |
Why?
|
Infant | 13 | 2023 | 3189 | 0.600 |
Why?
|
Bioethical Issues | 1 | 2018 | 38 | 0.600 |
Why?
|
Graft Survival | 9 | 2019 | 908 | 0.590 |
Why?
|
Thorax | 2 | 2017 | 77 | 0.590 |
Why?
|
Sternum | 4 | 2010 | 35 | 0.580 |
Why?
|
Toes | 1 | 2017 | 14 | 0.580 |
Why?
|
Patient Care | 1 | 2018 | 102 | 0.560 |
Why?
|
Treatment Outcome | 16 | 2024 | 8270 | 0.560 |
Why?
|
Surgical Wound Infection | 8 | 2015 | 203 | 0.520 |
Why?
|
Severity of Illness Index | 3 | 2021 | 1859 | 0.520 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 262 | 0.520 |
Why?
|
Hidradenitis Suppurativa | 1 | 2016 | 12 | 0.520 |
Why?
|
Internal Fixators | 1 | 2015 | 15 | 0.510 |
Why?
|
Ethics, Medical | 1 | 2018 | 306 | 0.510 |
Why?
|
Sternotomy | 1 | 2015 | 24 | 0.500 |
Why?
|
Bandages | 5 | 2024 | 42 | 0.480 |
Why?
|
Health Services Accessibility | 1 | 2018 | 436 | 0.480 |
Why?
|
Nasal Septal Perforation | 1 | 2014 | 3 | 0.470 |
Why?
|
Liver Transplantation | 2 | 2013 | 1175 | 0.470 |
Why?
|
Nasal Septum | 1 | 2014 | 28 | 0.460 |
Why?
|
Wound Healing | 11 | 2021 | 361 | 0.460 |
Why?
|
Surgery, Plastic | 8 | 2012 | 42 | 0.450 |
Why?
|
Contracture | 2 | 2017 | 18 | 0.450 |
Why?
|
Young Adult | 12 | 2019 | 6408 | 0.450 |
Why?
|
Coloring Agents | 2 | 2010 | 65 | 0.440 |
Why?
|
Critical Care | 3 | 2024 | 384 | 0.440 |
Why?
|
Neural Tube Defects | 1 | 2014 | 45 | 0.440 |
Why?
|
Reoperation | 9 | 2019 | 604 | 0.430 |
Why?
|
Skin | 6 | 2008 | 589 | 0.420 |
Why?
|
Burn Units | 6 | 2023 | 21 | 0.410 |
Why?
|
Decision Making | 1 | 2018 | 670 | 0.410 |
Why?
|
Mammaplasty | 3 | 2009 | 110 | 0.400 |
Why?
|
Household Products | 1 | 2011 | 9 | 0.390 |
Why?
|
Facial Asymmetry | 1 | 2011 | 12 | 0.390 |
Why?
|
Drainage | 3 | 2010 | 165 | 0.390 |
Why?
|
Facial Transplantation | 1 | 2011 | 15 | 0.380 |
Why?
|
Face | 2 | 2009 | 118 | 0.380 |
Why?
|
Fibula | 2 | 2008 | 32 | 0.380 |
Why?
|
Purpura Fulminans | 1 | 2011 | 2 | 0.380 |
Why?
|
Child Behavior | 1 | 2011 | 47 | 0.380 |
Why?
|
Muscle, Skeletal | 4 | 2012 | 471 | 0.380 |
Why?
|
Head | 3 | 2009 | 137 | 0.370 |
Why?
|
Epigastric Arteries | 2 | 2009 | 9 | 0.370 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2011 | 26 | 0.370 |
Why?
|
Follow-Up Studies | 10 | 2024 | 3680 | 0.360 |
Why?
|
Methylene Blue | 1 | 2010 | 18 | 0.360 |
Why?
|
Hyperoxaluria | 1 | 2010 | 26 | 0.360 |
Why?
|
Cicatrix | 2 | 2008 | 68 | 0.360 |
Why?
|
Fires | 1 | 2010 | 21 | 0.360 |
Why?
|
Foreign-Body Reaction | 1 | 2010 | 12 | 0.350 |
Why?
|
Cervicoplasty | 1 | 2010 | 1 | 0.350 |
Why?
|
Hair Removal | 1 | 2010 | 14 | 0.350 |
Why?
|
Pain Measurement | 3 | 2015 | 332 | 0.350 |
Why?
|
Alopecia | 1 | 2010 | 34 | 0.350 |
Why?
|
Ilium | 1 | 2010 | 18 | 0.340 |
Why?
|
Chimera | 1 | 2009 | 56 | 0.340 |
Why?
|
Penile Prosthesis | 4 | 2017 | 25 | 0.330 |
Why?
|
Forehead | 1 | 2009 | 15 | 0.330 |
Why?
|
Lidocaine | 1 | 2009 | 65 | 0.330 |
Why?
|
Urethral Stricture | 2 | 2015 | 14 | 0.330 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2013 | 1352 | 0.320 |
Why?
|
Rejuvenation | 1 | 2009 | 21 | 0.320 |
Why?
|
Anesthetics, Local | 1 | 2009 | 77 | 0.320 |
Why?
|
Zygomycosis | 1 | 2008 | 3 | 0.320 |
Why?
|
Skin Aging | 1 | 2009 | 30 | 0.320 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 191 | 0.310 |
Why?
|
Posture | 1 | 2008 | 125 | 0.310 |
Why?
|
Neck Injuries | 1 | 2008 | 13 | 0.310 |
Why?
|
Internship and Residency | 1 | 2017 | 1062 | 0.290 |
Why?
|
Hospitalization | 2 | 2023 | 888 | 0.290 |
Why?
|
Pain | 1 | 2009 | 399 | 0.280 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 414 | 0.270 |
Why?
|
Hemodynamics | 1 | 2010 | 738 | 0.270 |
Why?
|
Sewage | 1 | 2006 | 3 | 0.260 |
Why?
|
Explosions | 1 | 2006 | 6 | 0.260 |
Why?
|
Pharyngeal Neoplasms | 1 | 2006 | 15 | 0.260 |
Why?
|
Methane | 1 | 2006 | 13 | 0.260 |
Why?
|
Neoplasms, Second Primary | 1 | 2008 | 260 | 0.250 |
Why?
|
Thoracic Wall | 2 | 2016 | 25 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 1 | 2010 | 480 | 0.240 |
Why?
|
Living Donors | 2 | 2022 | 339 | 0.240 |
Why?
|
Amputation, Traumatic | 2 | 2002 | 9 | 0.230 |
Why?
|
Mouth Mucosa | 2 | 2015 | 68 | 0.230 |
Why?
|
Frailty | 2 | 2024 | 79 | 0.230 |
Why?
|
Anti-Infective Agents, Local | 2 | 2023 | 24 | 0.220 |
Why?
|
Coated Materials, Biocompatible | 2 | 2021 | 30 | 0.220 |
Why?
|
Shock, Septic | 2 | 2023 | 105 | 0.220 |
Why?
|
Facial Injuries | 2 | 2017 | 20 | 0.220 |
Why?
|
Esophageal Neoplasms | 1 | 2006 | 332 | 0.210 |
Why?
|
Antifibrinolytic Agents | 2 | 2023 | 39 | 0.210 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 1098 | 0.210 |
Why?
|
Guidelines as Topic | 2 | 2017 | 158 | 0.210 |
Why?
|
Hypospadias | 1 | 2002 | 7 | 0.210 |
Why?
|
Hemostatics | 1 | 2023 | 58 | 0.210 |
Why?
|
Length of Stay | 5 | 2023 | 748 | 0.200 |
Why?
|
Ischemia | 3 | 2021 | 253 | 0.200 |
Why?
|
Anti-Infective Agents | 1 | 2023 | 91 | 0.200 |
Why?
|
Soft Tissue Injuries | 2 | 2017 | 15 | 0.180 |
Why?
|
Patient Readmission | 1 | 2024 | 354 | 0.180 |
Why?
|
Nursing Staff, Hospital | 1 | 2020 | 42 | 0.170 |
Why?
|
Physician-Patient Relations | 2 | 2018 | 624 | 0.170 |
Why?
|
Radiotherapy | 2 | 2015 | 332 | 0.170 |
Why?
|
Body Surface Area | 2 | 2021 | 36 | 0.170 |
Why?
|
Surgeons | 1 | 2024 | 249 | 0.170 |
Why?
|
Nutritional Requirements | 1 | 1999 | 17 | 0.170 |
Why?
|
Job Satisfaction | 1 | 2020 | 79 | 0.170 |
Why?
|
Carotid Artery Injuries | 2 | 2010 | 22 | 0.160 |
Why?
|
Heart Transplantation | 2 | 2016 | 730 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2020 | 387 | 0.160 |
Why?
|
Mandibular Reconstruction | 1 | 2019 | 3 | 0.160 |
Why?
|
Tissue Plasminogen Activator | 1 | 2021 | 173 | 0.160 |
Why?
|
Transplantation Chimera | 1 | 2019 | 81 | 0.160 |
Why?
|
Risk Factors | 5 | 2024 | 5555 | 0.160 |
Why?
|
Finger Injuries | 1 | 1998 | 12 | 0.160 |
Why?
|
Illinois | 2 | 2011 | 485 | 0.160 |
Why?
|
Patient Reported Outcome Measures | 1 | 2020 | 195 | 0.160 |
Why?
|
Burnout, Professional | 1 | 2020 | 102 | 0.150 |
Why?
|
Incidence | 3 | 2017 | 1601 | 0.150 |
Why?
|
Buttocks | 1 | 1998 | 10 | 0.150 |
Why?
|
Medical Futility | 1 | 2018 | 31 | 0.150 |
Why?
|
Patient Care Planning | 1 | 2018 | 83 | 0.150 |
Why?
|
Mental Competency | 1 | 2018 | 49 | 0.150 |
Why?
|
Urban Population | 1 | 2019 | 225 | 0.150 |
Why?
|
Hand | 2 | 2015 | 142 | 0.150 |
Why?
|
Bacterial Infections | 3 | 2017 | 184 | 0.140 |
Why?
|
Administration, Topical | 2 | 2023 | 96 | 0.140 |
Why?
|
Energy Metabolism | 1 | 1999 | 282 | 0.140 |
Why?
|
Suture Anchors | 1 | 2017 | 5 | 0.140 |
Why?
|
Cadaver | 1 | 2017 | 186 | 0.140 |
Why?
|
Pubic Bone | 1 | 2017 | 9 | 0.140 |
Why?
|
Range of Motion, Articular | 2 | 2017 | 157 | 0.140 |
Why?
|
Arteries | 2 | 2013 | 179 | 0.140 |
Why?
|
Esthetics | 3 | 2007 | 45 | 0.140 |
Why?
|
Sympathectomy | 2 | 2011 | 17 | 0.140 |
Why?
|
Osteomyelitis | 3 | 2015 | 55 | 0.140 |
Why?
|
Child Welfare | 1 | 2017 | 38 | 0.140 |
Why?
|
Hair | 2 | 2022 | 56 | 0.140 |
Why?
|
Drug Resistance, Bacterial | 1 | 2017 | 76 | 0.140 |
Why?
|
Hydrotherapy | 1 | 2016 | 5 | 0.130 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 125 | 0.130 |
Why?
|
Prosthesis Implantation | 1 | 2017 | 129 | 0.130 |
Why?
|
Rhytidoplasty | 1 | 2015 | 12 | 0.120 |
Why?
|
Temporal Muscle | 1 | 2015 | 12 | 0.120 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2015 | 10 | 0.120 |
Why?
|
Facial Paralysis | 1 | 2015 | 17 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 151 | 0.120 |
Why?
|
Surgically-Created Structures | 1 | 2015 | 5 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 84 | 0.120 |
Why?
|
Meningitis | 1 | 2015 | 21 | 0.120 |
Why?
|
Suction | 1 | 2015 | 37 | 0.120 |
Why?
|
Surveys and Questionnaires | 4 | 2020 | 2653 | 0.120 |
Why?
|
Thymus Gland | 1 | 2016 | 197 | 0.120 |
Why?
|
Reproducibility of Results | 3 | 2017 | 2767 | 0.120 |
Why?
|
Models, Animal | 1 | 2016 | 277 | 0.120 |
Why?
|
Composite Tissue Allografts | 1 | 2014 | 7 | 0.120 |
Why?
|
Fascia Lata | 1 | 2014 | 7 | 0.120 |
Why?
|
United States | 6 | 2024 | 7102 | 0.120 |
Why?
|
Laparoscopy | 1 | 2021 | 780 | 0.120 |
Why?
|
Materials Testing | 1 | 1994 | 93 | 0.110 |
Why?
|
Water | 2 | 2022 | 286 | 0.110 |
Why?
|
Cartilage | 1 | 2014 | 116 | 0.110 |
Why?
|
Transplantation, Homologous | 2 | 2016 | 995 | 0.110 |
Why?
|
Sutures | 1 | 1994 | 57 | 0.110 |
Why?
|
Rotation | 1 | 2014 | 91 | 0.110 |
Why?
|
Bacteria | 2 | 2017 | 486 | 0.110 |
Why?
|
Radial Artery | 2 | 2009 | 33 | 0.110 |
Why?
|
Disorders of Sex Development | 1 | 1993 | 18 | 0.110 |
Why?
|
Fracture Fixation, Internal | 1 | 1994 | 69 | 0.110 |
Why?
|
Tibial Nerve | 1 | 1993 | 14 | 0.110 |
Why?
|
Abdominal Muscles | 2 | 2010 | 19 | 0.110 |
Why?
|
Nerve Regeneration | 1 | 1993 | 36 | 0.110 |
Why?
|
Algorithms | 3 | 2012 | 1908 | 0.110 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 401 | 0.110 |
Why?
|
Chicago | 2 | 2015 | 1431 | 0.110 |
Why?
|
Fractures, Bone | 1 | 1994 | 133 | 0.100 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 2012 | 8 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2015 | 384 | 0.100 |
Why?
|
Intraoperative Period | 2 | 2009 | 91 | 0.100 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 1993 | 191 | 0.100 |
Why?
|
Coercion | 1 | 2012 | 15 | 0.100 |
Why?
|
Adhesins, Bacterial | 1 | 2012 | 36 | 0.100 |
Why?
|
Suture Techniques | 2 | 2011 | 144 | 0.100 |
Why?
|
Anti-Bacterial Agents | 2 | 2016 | 798 | 0.100 |
Why?
|
Vesicovaginal Fistula | 2 | 2008 | 12 | 0.100 |
Why?
|
Longitudinal Studies | 1 | 2015 | 1083 | 0.100 |
Why?
|
Lectins | 1 | 2012 | 84 | 0.100 |
Why?
|
Clinical Competence | 1 | 2017 | 795 | 0.100 |
Why?
|
Moral Obligations | 1 | 2012 | 53 | 0.100 |
Why?
|
Lower Extremity | 1 | 2012 | 88 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2012 | 99 | 0.090 |
Why?
|
Microcirculation | 2 | 2009 | 105 | 0.090 |
Why?
|
Survival Rate | 1 | 2015 | 1898 | 0.090 |
Why?
|
Personal Autonomy | 1 | 2012 | 115 | 0.090 |
Why?
|
Smoke Inhalation Injury | 1 | 2010 | 7 | 0.090 |
Why?
|
Acute Disease | 2 | 2011 | 846 | 0.090 |
Why?
|
Protective Devices | 1 | 2010 | 8 | 0.090 |
Why?
|
Morphine | 1 | 2012 | 130 | 0.090 |
Why?
|
Infant, Newborn | 2 | 2014 | 2498 | 0.090 |
Why?
|
Burns, Electric | 1 | 1990 | 5 | 0.090 |
Why?
|
Hydroxyapatites | 1 | 2010 | 7 | 0.090 |
Why?
|
Molar | 1 | 2010 | 22 | 0.090 |
Why?
|
Arm Injuries | 1 | 1990 | 10 | 0.090 |
Why?
|
Oral Surgical Procedures | 1 | 2010 | 19 | 0.090 |
Why?
|
Maxillary Sinus Neoplasms | 1 | 2010 | 8 | 0.090 |
Why?
|
Hemostasis, Surgical | 1 | 2010 | 25 | 0.090 |
Why?
|
Abdomen | 1 | 2010 | 124 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2012 | 203 | 0.090 |
Why?
|
Fasciotomy | 1 | 2010 | 17 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 347 | 0.090 |
Why?
|
Fatal Outcome | 1 | 2010 | 296 | 0.090 |
Why?
|
Indocyanine Green | 1 | 2009 | 22 | 0.090 |
Why?
|
Tongue Neoplasms | 1 | 2010 | 52 | 0.080 |
Why?
|
Arteriovenous Malformations | 1 | 2010 | 45 | 0.080 |
Why?
|
Quality of Life | 1 | 2018 | 1680 | 0.080 |
Why?
|
Lasers | 1 | 2009 | 107 | 0.080 |
Why?
|
Perfusion | 1 | 2011 | 253 | 0.080 |
Why?
|
Iliac Artery | 1 | 2009 | 41 | 0.080 |
Why?
|
Ribs | 1 | 2009 | 46 | 0.080 |
Why?
|
Femoral Artery | 1 | 2009 | 84 | 0.080 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2010 | 109 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2012 | 256 | 0.080 |
Why?
|
Surgical Equipment | 1 | 2008 | 4 | 0.080 |
Why?
|
Angiography | 1 | 2009 | 208 | 0.080 |
Why?
|
Neck | 2 | 2009 | 104 | 0.080 |
Why?
|
Hyperbaric Oxygenation | 3 | 1996 | 13 | 0.080 |
Why?
|
Penile Implantation | 1 | 2009 | 14 | 0.080 |
Why?
|
Bone Diseases, Infectious | 1 | 2008 | 1 | 0.080 |
Why?
|
Mandible | 1 | 2010 | 121 | 0.080 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2008 | 3 | 0.080 |
Why?
|
Dermatomycoses | 1 | 2008 | 9 | 0.080 |
Why?
|
Cavernous Sinus | 1 | 1988 | 15 | 0.080 |
Why?
|
Nose Diseases | 1 | 2008 | 11 | 0.080 |
Why?
|
Radiography, Interventional | 1 | 2010 | 157 | 0.080 |
Why?
|
Trauma Severity Indices | 1 | 2008 | 44 | 0.080 |
Why?
|
Breast | 2 | 2009 | 292 | 0.080 |
Why?
|
Orbital Diseases | 1 | 2008 | 21 | 0.080 |
Why?
|
Paranasal Sinus Diseases | 1 | 2008 | 25 | 0.080 |
Why?
|
Thoracic Arteries | 1 | 2008 | 6 | 0.080 |
Why?
|
Obesity | 1 | 2015 | 972 | 0.070 |
Why?
|
Sarcoma | 1 | 2010 | 219 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2012 | 283 | 0.070 |
Why?
|
Arteriovenous Fistula | 1 | 1988 | 53 | 0.070 |
Why?
|
Sepsis | 1 | 2012 | 330 | 0.070 |
Why?
|
Blood Vessel Prosthesis | 1 | 2010 | 244 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2010 | 198 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2008 | 123 | 0.070 |
Why?
|
Survival Analysis | 1 | 2011 | 1497 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2009 | 1714 | 0.070 |
Why?
|
Mastectomy | 1 | 2009 | 246 | 0.070 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 451 | 0.070 |
Why?
|
Databases, Factual | 2 | 2024 | 865 | 0.070 |
Why?
|
Tissue and Organ Procurement | 1 | 2012 | 359 | 0.070 |
Why?
|
Vacuum | 2 | 2005 | 10 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 806 | 0.070 |
Why?
|
Stents | 1 | 2010 | 412 | 0.070 |
Why?
|
Wounds, Gunshot | 1 | 1988 | 99 | 0.070 |
Why?
|
Electricity | 1 | 2006 | 24 | 0.060 |
Why?
|
Liver | 1 | 2010 | 1211 | 0.060 |
Why?
|
Fournier Gangrene | 1 | 2005 | 2 | 0.060 |
Why?
|
Tissue Expansion | 1 | 2005 | 20 | 0.060 |
Why?
|
Scrotum | 1 | 2005 | 18 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 1988 | 265 | 0.060 |
Why?
|
Rats | 5 | 1996 | 4048 | 0.060 |
Why?
|
Air Pollution, Indoor | 1 | 2006 | 64 | 0.060 |
Why?
|
Occlusive Dressings | 2 | 2015 | 7 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 2018 | 0.060 |
Why?
|
Lymphedema | 2 | 2004 | 77 | 0.060 |
Why?
|
Genital Diseases, Male | 1 | 2004 | 9 | 0.060 |
Why?
|
Erectile Dysfunction | 1 | 2005 | 76 | 0.060 |
Why?
|
Regional Blood Flow | 2 | 2009 | 198 | 0.060 |
Why?
|
Autografts | 1 | 2024 | 29 | 0.060 |
Why?
|
Accidents, Traffic | 2 | 2012 | 98 | 0.060 |
Why?
|
Animals | 12 | 2016 | 27526 | 0.060 |
Why?
|
Pediatrics | 1 | 2008 | 360 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2010 | 856 | 0.060 |
Why?
|
Fingers | 2 | 1998 | 69 | 0.060 |
Why?
|
Beverages | 1 | 2023 | 17 | 0.050 |
Why?
|
Nutritional Status | 2 | 2001 | 81 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2023 | 56 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 3 | 1996 | 1237 | 0.050 |
Why?
|
Lymph Node Excision | 1 | 2004 | 220 | 0.050 |
Why?
|
Midwestern United States | 1 | 2022 | 83 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2023 | 116 | 0.050 |
Why?
|
Gender Identity | 1 | 2022 | 53 | 0.050 |
Why?
|
Jejunum | 1 | 2002 | 80 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2009 | 1054 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2001 | 23 | 0.050 |
Why?
|
Perineum | 1 | 2001 | 36 | 0.050 |
Why?
|
Wound Infection | 3 | 1997 | 17 | 0.050 |
Why?
|
Glutamine | 1 | 2001 | 79 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2017 | 1864 | 0.050 |
Why?
|
Vitamin E | 2 | 1991 | 32 | 0.050 |
Why?
|
Vitamin A | 2 | 1991 | 28 | 0.050 |
Why?
|
Esophagus | 1 | 2021 | 107 | 0.050 |
Why?
|
Rectum | 1 | 2001 | 148 | 0.040 |
Why?
|
Rewarming | 1 | 2000 | 5 | 0.040 |
Why?
|
Nurse-Patient Relations | 1 | 2020 | 13 | 0.040 |
Why?
|
Bites, Human | 2 | 1998 | 2 | 0.040 |
Why?
|
Respiration, Artificial | 1 | 2022 | 358 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2022 | 345 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2022 | 408 | 0.040 |
Why?
|
China | 1 | 2020 | 235 | 0.040 |
Why?
|
Postoperative Period | 1 | 2020 | 301 | 0.040 |
Why?
|
Mandibular Diseases | 1 | 2019 | 16 | 0.040 |
Why?
|
Trachea | 1 | 2020 | 292 | 0.040 |
Why?
|
Anthropometry | 1 | 1999 | 76 | 0.040 |
Why?
|
Osteoradionecrosis | 1 | 2019 | 18 | 0.040 |
Why?
|
Inpatients | 1 | 2022 | 312 | 0.040 |
Why?
|
Mandibular Neoplasms | 1 | 2019 | 23 | 0.040 |
Why?
|
Bites and Stings | 1 | 1998 | 9 | 0.040 |
Why?
|
Lip | 1 | 1998 | 16 | 0.040 |
Why?
|
Operative Time | 1 | 2019 | 147 | 0.040 |
Why?
|
Replantation | 1 | 1998 | 36 | 0.040 |
Why?
|
Stress, Mechanical | 3 | 1994 | 253 | 0.040 |
Why?
|
Radionuclide Imaging | 1 | 1998 | 222 | 0.040 |
Why?
|
Patellar Ligament | 1 | 1997 | 14 | 0.040 |
Why?
|
Dogs | 1 | 1998 | 706 | 0.040 |
Why?
|
Patient Discharge | 1 | 2020 | 326 | 0.040 |
Why?
|
Composite Resins | 1 | 2017 | 4 | 0.040 |
Why?
|
Prospective Studies | 3 | 2015 | 4325 | 0.040 |
Why?
|
Knee Prosthesis | 1 | 1997 | 32 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 1998 | 160 | 0.030 |
Why?
|
Iatrogenic Disease | 1 | 1997 | 70 | 0.030 |
Why?
|
Hospitals, Urban | 1 | 1997 | 60 | 0.030 |
Why?
|
Allopurinol | 1 | 2017 | 77 | 0.030 |
Why?
|
Gout Suppressants | 1 | 2017 | 35 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2017 | 151 | 0.030 |
Why?
|
Biomechanical Phenomena | 3 | 1993 | 477 | 0.030 |
Why?
|
Malpractice | 1 | 2017 | 57 | 0.030 |
Why?
|
Time Factors | 2 | 2017 | 5357 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 1997 | 118 | 0.030 |
Why?
|
Leg | 1 | 1997 | 140 | 0.030 |
Why?
|
Gout | 1 | 2017 | 75 | 0.030 |
Why?
|
Injury Severity Score | 1 | 2017 | 144 | 0.030 |
Why?
|
Hyperoxia | 1 | 1996 | 35 | 0.030 |
Why?
|
Bone and Bones | 1 | 1997 | 271 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2009 | 3021 | 0.030 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 1996 | 80 | 0.030 |
Why?
|
Smiling | 1 | 2015 | 2 | 0.030 |
Why?
|
Needs Assessment | 1 | 2017 | 161 | 0.030 |
Why?
|
Facial Expression | 1 | 2015 | 52 | 0.030 |
Why?
|
Crohn Disease | 1 | 2001 | 764 | 0.030 |
Why?
|
Adjustment Disorders | 1 | 1994 | 6 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 1729 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 1994 | 53 | 0.030 |
Why?
|
Random Allocation | 2 | 2012 | 327 | 0.030 |
Why?
|
Prognosis | 1 | 2022 | 3796 | 0.030 |
Why?
|
Sarcoidosis | 1 | 1994 | 72 | 0.030 |
Why?
|
Tendons | 2 | 1991 | 44 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 1996 | 146 | 0.030 |
Why?
|
Elasticity | 1 | 1994 | 97 | 0.030 |
Why?
|
Sex Factors | 1 | 2017 | 1075 | 0.030 |
Why?
|
Streptozocin | 1 | 1993 | 55 | 0.030 |
Why?
|
Up-Regulation | 1 | 1996 | 726 | 0.030 |
Why?
|
Scapula | 1 | 1993 | 24 | 0.030 |
Why?
|
Chondrosarcoma | 1 | 1993 | 50 | 0.030 |
Why?
|
Pressure | 1 | 1993 | 167 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 1994 | 198 | 0.030 |
Why?
|
Rats, Wistar | 1 | 1993 | 303 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 72 | 0.030 |
Why?
|
Motorcycles | 1 | 2012 | 11 | 0.030 |
Why?
|
Dextrans | 1 | 2012 | 79 | 0.030 |
Why?
|
Age Factors | 1 | 2017 | 1880 | 0.020 |
Why?
|
Colonic Polyps | 1 | 1993 | 132 | 0.020 |
Why?
|
Chemotaxis | 1 | 2012 | 73 | 0.020 |
Why?
|
Hospital Costs | 1 | 2012 | 109 | 0.020 |
Why?
|
Warfarin | 1 | 2012 | 104 | 0.020 |
Why?
|
Body Mass Index | 1 | 2015 | 776 | 0.020 |
Why?
|
Virulence Factors | 1 | 2012 | 112 | 0.020 |
Why?
|
Linear Models | 1 | 2012 | 421 | 0.020 |
Why?
|
Mice | 3 | 2016 | 11851 | 0.020 |
Why?
|
Virulence | 1 | 2012 | 282 | 0.020 |
Why?
|
Chronic Disease | 1 | 1994 | 958 | 0.020 |
Why?
|
Adenoma | 1 | 1993 | 250 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2012 | 283 | 0.020 |
Why?
|
Hand Deformities, Acquired | 1 | 1990 | 5 | 0.020 |
Why?
|
Forearm Injuries | 1 | 1990 | 4 | 0.020 |
Why?
|
Tendon Injuries | 1 | 1990 | 36 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2010 | 22 | 0.020 |
Why?
|
Alveolar Bone Loss | 1 | 2010 | 20 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 1993 | 321 | 0.020 |
Why?
|
Cohort Studies | 1 | 2017 | 2887 | 0.020 |
Why?
|
Angiography, Digital Subtraction | 1 | 2010 | 99 | 0.020 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2009 | 42 | 0.020 |
Why?
|
Carcinoma | 1 | 1993 | 438 | 0.020 |
Why?
|
Streptococcus pyogenes | 1 | 1989 | 35 | 0.020 |
Why?
|
Culture Techniques | 3 | 1996 | 91 | 0.020 |
Why?
|
Lung | 1 | 1996 | 1292 | 0.020 |
Why?
|
Risk Assessment | 1 | 2017 | 2327 | 0.020 |
Why?
|
Anticoagulants | 1 | 2012 | 431 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 1994 | 684 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2009 | 149 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 1988 | 59 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 571 | 0.020 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1988 | 22 | 0.020 |
Why?
|
Mafenide | 1 | 1988 | 1 | 0.020 |
Why?
|
Dermatitis, Contact | 1 | 1988 | 6 | 0.020 |
Why?
|
Punctures | 1 | 1988 | 30 | 0.020 |
Why?
|
Cartilage Diseases | 1 | 1988 | 18 | 0.020 |
Why?
|
Complement System Proteins | 1 | 1988 | 82 | 0.020 |
Why?
|
Blood Specimen Collection | 1 | 1988 | 27 | 0.020 |
Why?
|
Drug Eruptions | 1 | 1988 | 33 | 0.020 |
Why?
|
Elastic Tissue | 1 | 1986 | 18 | 0.020 |
Why?
|
Urologic Surgical Procedures | 1 | 2008 | 149 | 0.020 |
Why?
|
Staphylococcus aureus | 1 | 1989 | 278 | 0.020 |
Why?
|
Premedication | 1 | 1985 | 57 | 0.020 |
Why?
|
Bone Plates | 1 | 2005 | 23 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 2004 | 1185 | 0.020 |
Why?
|
Sulfonamides | 1 | 1988 | 319 | 0.020 |
Why?
|
Diabetic Angiopathies | 1 | 2005 | 37 | 0.020 |
Why?
|
Rabbits | 3 | 1991 | 640 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 1988 | 1704 | 0.010 |
Why?
|
Rupture | 2 | 1997 | 61 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1994 | 2677 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2005 | 230 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2005 | 264 | 0.010 |
Why?
|
Staphylococcal Infections | 2 | 1996 | 272 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1988 | 1394 | 0.010 |
Why?
|
Comorbidity | 1 | 2005 | 953 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 2001 | 105 | 0.010 |
Why?
|
Intestinal Neoplasms | 1 | 2001 | 68 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2001 | 191 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2005 | 364 | 0.010 |
Why?
|
Hypertension | 1 | 2005 | 747 | 0.010 |
Why?
|
Cicatrix, Hypertrophic | 1 | 1998 | 8 | 0.010 |
Why?
|
Canes | 1 | 1997 | 2 | 0.010 |
Why?
|
Walkers | 1 | 1997 | 2 | 0.010 |
Why?
|
Wheelchairs | 1 | 1997 | 9 | 0.010 |
Why?
|
Achilles Tendon | 1 | 1997 | 15 | 0.010 |
Why?
|
Patella | 1 | 1997 | 33 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 1994 | 1607 | 0.010 |
Why?
|
Walking | 1 | 1997 | 93 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1997 | 286 | 0.010 |
Why?
|
Health Services Research | 1 | 1997 | 138 | 0.010 |
Why?
|
Electric Power Supplies | 1 | 1996 | 8 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1996 | 258 | 0.010 |
Why?
|
Retroperitoneal Space | 1 | 1996 | 38 | 0.010 |
Why?
|
Surgical Wound Dehiscence | 1 | 1996 | 37 | 0.010 |
Why?
|
Heart Failure | 1 | 2005 | 1252 | 0.010 |
Why?
|
Pancreatic Ducts | 1 | 1994 | 30 | 0.010 |
Why?
|
Cholangiography | 1 | 1994 | 43 | 0.010 |
Why?
|
Psychology, Child | 1 | 1994 | 12 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 1994 | 68 | 0.010 |
Why?
|
Psychology, Adolescent | 1 | 1994 | 29 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 1994 | 76 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1996 | 899 | 0.010 |
Why?
|
Self Concept | 1 | 1994 | 135 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 1738 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 312 | 0.010 |
Why?
|
Fasciitis | 1 | 1991 | 10 | 0.010 |
Why?
|
Compartment Syndromes | 1 | 1991 | 13 | 0.010 |
Why?
|
Precancerous Conditions | 1 | 1993 | 200 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 1996 | 1801 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 1993 | 569 | 0.010 |
Why?
|
Colonoscopy | 1 | 1993 | 281 | 0.010 |
Why?
|
Palliative Care | 1 | 1993 | 264 | 0.010 |
Why?
|
Decompression Sickness | 1 | 1990 | 2 | 0.010 |
Why?
|
Carbon Monoxide Poisoning | 1 | 1990 | 18 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 1993 | 983 | 0.010 |
Why?
|
Radiation Injuries | 1 | 1991 | 161 | 0.010 |
Why?
|
Embolism, Air | 1 | 1990 | 23 | 0.010 |
Why?
|
RNA, Messenger | 1 | 1996 | 2026 | 0.010 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 1989 | 29 | 0.010 |
Why?
|
Plasminogen | 1 | 1989 | 45 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 1990 | 996 | 0.010 |
Why?
|
Hysterectomy | 1 | 1990 | 156 | 0.000 |
Why?
|
Graft Enhancement, Immunologic | 1 | 1988 | 13 | 0.000 |
Why?
|
Langerhans Cells | 1 | 1988 | 14 | 0.000 |
Why?
|
Ointments | 1 | 1988 | 12 | 0.000 |
Why?
|
Cephalothin | 1 | 1988 | 2 | 0.000 |
Why?
|
Biological Dressings | 1 | 1988 | 5 | 0.000 |
Why?
|
Hand Dermatoses | 1 | 1988 | 9 | 0.000 |
Why?
|
Otitis Externa | 1 | 1988 | 5 | 0.000 |
Why?
|
Phenytoin | 1 | 1988 | 15 | 0.000 |
Why?
|
Clostridium Infections | 1 | 1990 | 125 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1996 | 1983 | 0.000 |
Why?
|
Pneumonia | 1 | 1988 | 183 | 0.000 |
Why?
|
Hemorrhage | 1 | 1988 | 287 | 0.000 |
Why?
|
Congenital Abnormalities | 1 | 1985 | 64 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1988 | 341 | 0.000 |
Why?
|
Drug Utilization | 1 | 1985 | 66 | 0.000 |
Why?
|
Data Collection | 1 | 1985 | 377 | 0.000 |
Why?
|
Models, Biological | 1 | 1989 | 1765 | 0.000 |
Why?
|
Neoplasms | 1 | 1997 | 3065 | 0.000 |
Why?
|